SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as community members discuss its long-term potential, with many users sharing optimism that the project will eventually rebound from its current lows. Discussions frequently highlight the earn-while-moving model and the importance of patience, often referencing the token alongside the NEAR protocol.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is generating significant community interest driven by its expanding AI-centric infrastructure and the growing adoption of its 'Intents' cross-chain swap protocol. Investors are actively discussing the token's long-term utility in the AI economy, with many viewing current price levels as an accumulation opportunity despite broader market volatility.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is surging in community sentiment following the positive resolution of a multi-year SEC investigation, a development investors view as a major catalyst for its RWA-focused platform. The community is actively debating the project's long-term potential as a leader in asset tokenization while navigating concerns surrounding future token unlocks.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant (QNT) is drawing attention as investors weigh its role as a key enterprise-grade infrastructure player for tokenized banking and interoperability against ongoing frustration with its recent price stagnation. While community members highlight potential supply shocks and upcoming staking milestones as bullish drivers, many are actively debating whether to accumulate during current levels or remain sidelined until significant technical resistance is breached.

Hormel Foods Corp. engages in the manufacturing and marketing of branded food products. It operates through the following segments: Retail, Foodservice, and International. The Retail segment consists of the processing, marketing, and sale of food products sold predominantly in the retail market. The Foodservice segment includes the processing, marketing, and sale of food and nutritional products for foodservice, convenience store, and commercial customers. The International segment focuses on processing, marketing, and selling company products internationally. The company was founded by George A. Hormel in 1891 and is headquartered in Austin, MN.

Hormel Foods Corp.

Hormel Foods is trending as investors monitor the company's efforts to navigate significant margin pressures driven by persistent commodity cost inflation. The community is actively discussing its defensive role as a dividend-paying staple, with many weighing whether current valuations present a long-term accumulation opportunity despite the company's recent earnings volatility.

Conagra Brands, Inc. engages in the manufacture and sale of processed and packaged foods. It operates through the following segments: Grocery and Snacks, Refrigerated and Frozen, International, and Foodservice. The Grocery and Snacks segment includes branded, and shelf stable food products sold in various retail channels in the United States. The Refrigerated and Frozen segment is composed of branded, and temperature-controlled food products sold in various retail channels in the United States. The International segment offers branded food products in various temperature states, sold in various retail and foodservice channels outside of the United States. The Foodservice segment focuses on branded and customized food products, including meals, entrees, sauces, and a variety of custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The company was founded by Alva Kinney and Frank Little in 1919 and is headquartered in Chicago, IL.

Conagra Brands Inc

Conagra Brands is attracting attention as investors rotate toward undervalued consumer staples, driven by the stock's significant dividend yield and a recent leadership transition to a new CEO. While some remain cautious due to ongoing margin pressures and SNAP-related demand headwinds, the community is debating whether the stock is hitting a generational bottom or remains a value trap.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is currently trending as investors debate its potential as an undervalued consumer staple with a strong dividend yield, amid active community discussion regarding a leadership-led strategic pivot and the impact of broader market rotation into defensive assets.

EHang Holdings Ltd. engages in the provision of aerial vehicle technology platform company. It also provides unmanned aerial vehicle (UAV) systems and solutions: air mobility (including human transportation and logistics), smart city management, and aerial media solutions. The firm operates through the following geographical segments: P.R.C., West Asia, East Asia, South America, Europe, and Other. The company was founded by Huazhi Hu and Yifang Derrick Xiong in December 2014 and is headquartered in Guangzhou, China.

EHang Holdings Ltd - ADR

EHang Holdings

EHang is trending due to the highly anticipated launch of its new VT35 long-range pilotless eVTOL, coupled with significant backing from the Chinese government's focus on the low-altitude economy. Despite ongoing market volatility and macro-related pressure on Chinese stocks, investors are closely monitoring these technological milestones and institutional accumulation as indicators of the company's long-term commercial potential.

Tractor Supply Co. engages in the retail sale of farm and ranch products. It operates retail farm and ranch stores and focuses on supplying the lifestyle needs of recreational farmers and ranchers, as well as tradesmen and small businesses. The firm operates the retail stores under the names: Tractor Supply Company, Orscheln Farm & Home, and Petsense. Its product categories include equine, livestock, pet, and small animal, hardware, truck, towing, and tool, heating, lawn and garden items, power equipment, gifts, and toys, recreational clothing and footwear, and maintenance products for agricultural and rural use. The company was founded by Charles E. Schmidt, Sr. in 1938 and is headquartered in Brentwood, TN.

Tractor Supply Co.

Tractor Supply Co. is trending as analysts adjust their ratings, with Citigroup upgrading TSCO to a buy, while others adjust price targets; Evercore ISI Group updates rating to In-Line. The community is discussing the company's potential for growth, with some pointing to its e-commerce and pet-related retail segments, while others focus on expansion plans and operational efficiency.

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic Plc

Medtronic is trending as investors and community members weigh its potential as a defensive income play against ongoing headwinds from GLP-1 sector rotation and mixed financial performance. Analysts and traders are closely monitoring key pipeline catalysts, such as robotic-assisted surgery platforms and cardiovascular technology, while discussing whether the stock currently offers an opportunistic entry point after recent downward price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sionna Therapeutics (NASDAQ:SION) Upgraded to "Strong-Buy" at Wedbush

Wedbush raised Sionna Therapeutics to a "strong-buy" rating in a report on Monday...

Sionna Therapeutics, Inc. $SION Shares Acquired by Jennison Associates LLC

Jennison Associates LLC increased its stake in Sionna Therapeutics, Inc. (NASDAQ:SION - Free Report) by 11.8% in the fourth quarter, according to its most recent 13F filing with the Securities...

JonesTrading Forecasts Strong Price Appreciation for Sionna Therapeutics (NASDAQ:SION) Stock

JonesTrading boosted their target price on Sionna Therapeutics from $52.00 to $63.00 and gave the stock a "buy" rating in a research report on Tuesday...

Sionna Insider Sells $2.5 Million in Stock Amid 215% Surge, but Here's What Investors Should Watch

Key PointsA director of Sionna Therapeutics reported the sale of 55,345 shares for a total transaction value of $2.47 million, using a weighted average price of $44.67 per share across April 17-18, 2026...

Sionna Therapeutics (NASDAQ:SION) Earns "Buy" Rating from BTIG Research

BTIG Research reissued a "buy" rating and set a $58.00 price target on shares of Sionna Therapeutics in a report on Monday...

Sionna Therapeutics (NASDAQ:SION) Stock Price Up 6.7% - Here's What Happened

Sionna Therapeutics (NASDAQ:SION) Stock Price Up 6.7% - Still a Buy...

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 11.3% - What's Next?

Sionna Therapeutics (NASDAQ:SION) Shares Down 11.3% - Here's What Happened...

Sionna Therapeutics (NASDAQ:SION) Director Orbimed Advisors Llc Sells 52,397 Shares

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Orbimed Advisors Llc sold 52,397 shares of the firm's stock in a transaction on Friday, April 17th. The shares were sold at an average price of $44.68, for a total value of $2,341,097.96. Following the transaction, the director...

Sionna Therapeutics (NASDAQ:SION) Director Peter Thompson Sells 52,397 Shares

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Peter Thompson sold 52,397 shares of Sionna Therapeutics stock in a transaction on Friday, April 17th. The shares were sold at an...

Sionna Therapeutics (NASDAQ:SION) Director Sells $2,341,097.96 in Stock

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Orbimed Advisors Llc sold 52,397 shares of Sionna Therapeutics stock in a transaction that occurred on Friday, April 17th. The stock...

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

Sionna Therapeutics Inc.

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.51	--	--	N/A
Q4 '25	-$0.54	-$0.46	14.66%	BEAT
Q3 '25	-$0.48	-$0.46	5.01%	BEAT
Q2 '25	-$0.56	-$0.41	26.13%	BEAT
Q1 '25	-$0.45	-$0.62	-38.55%	MISSED

SION
Sionna Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest SION News

SIONSionna Therapeutics Inc